1. Home
  2. FOXF vs ANNX Comparison

FOXF vs ANNX Comparison

Compare FOXF & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Factory Holding Corp.

FOXF

Fox Factory Holding Corp.

HOLD

Current Price

$17.08

Market Cap

793.0M

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.77

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXF
ANNX
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
793.0M
812.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
FOXF
ANNX
Price
$17.08
$5.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$30.25
$16.50
AVG Volume (30 Days)
625.4K
4.4M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,467,321,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.90
$16,320.74
P/E Ratio
N/A
N/A
Revenue Growth
5.27
N/A
52 Week Low
$13.08
$2.03
52 Week High
$31.18
$7.18

Technical Indicators

Market Signals
Indicator
FOXF
ANNX
Relative Strength Index (RSI) 46.65 55.54
Support Level $15.62 $4.75
Resistance Level $18.43 $5.89
Average True Range (ATR) 0.90 0.42
MACD -0.15 0.08
Stochastic Oscillator 36.64 54.60

Price Performance

Historical Comparison
FOXF
ANNX

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: